Home / Companies / Takeda Pharmaceuticals U S A Inc / Trends
Takeda Pharmaceuticals U S A Inc H-1B trends
Quarterly LCA aggregate trend points for Takeda Pharmaceuticals U S A Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Takeda Pharmaceuticals U S A Inc span 2016 Q2 to 2025 Q1, peaking at 10 filings in 2016 Q2.
The most recent reported period (2025 Q1) shows 1 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2016 Q2 | 10 | 9 | 5 | $92,780 | $91,040 | 10 | 100.0% |
| 2017 Q2 | 4 | 4 | 2 | $112,200 | $105,820 | 4 | 100.0% |
| 2018 Q2 | 8 | 8 | 4 | $100,651 | $89,328 | 8 | 100.0% |
| 2019 Q2 | 6 | 5 | 3 | $116,491 | $114,674 | 6 | 100.0% |
| 2020 Q2 | 1 | 1 | 1 | $78,666 | $73,944 | 1 | 100.0% |
| 2021 Q1 | 1 | 1 | 1 | $108,001 | $92,622 | 1 | 100.0% |
| 2021 Q2 | 1 | 1 | 1 | $108,001 | $92,622 | 1 | 100.0% |
| 2021 Q3 | 2 | 2 | 2 | $131,855 | $107,006 | 2 | 100.0% |
| 2025 Q1 | 1 | 1 | 1 | $164,307 | $152,693 | 1 | 100.0% |
Frequently asked questions
- How have H-1B filings for Takeda Pharmaceuticals U S A Inc changed over time?
- H-1B LCA filings for Takeda Pharmaceuticals U S A Inc span 2016 Q2 to 2025 Q1, peaking at 10 filings in 2016 Q2. The most recent reported period (2025 Q1) shows 1 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=takeda+pharmaceuticals+u+s+a+inc&metric=lca_countJSON